Precision targeting of MYD88 mutant DLBCL using the novel combination of irakimids and BCL2 inhibition Meeting Abstract


Authors: Grilo, A. M.; Klaus, C.; McDonald, A.; Gollob, J.; Weiss, M.; O'Connor, O. A.; Salles, G.; Chaudhuri, J.; Lue, J. K.
Abstract Title: Precision targeting of MYD88 mutant DLBCL using the novel combination of irakimids and BCL2 inhibition
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 8862
End Page: 8864
Language: English
ACCESSION: WOS:000893230301426
DOI: 10.1182/blood-2022-159567
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gilles Andre Salles
    272 Salles
  2. Jennifer Kimberly Lue
    34 Lue